Internal Medicine, Hematology & Oncology · Birmingham, AL
NPI
1831350198
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
513 Brookwood Blvd Ste 275
Birmingham, AL, 35209
Phone (205) 502-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
47,095 services
Medicare patients, 2024
436
Average age 75
Drug cost, 2024
$3.1M
2,824 prescriptions
Company payments, 2025
$46K
From 48 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Mooney was code J1437 (injection, ferric derisomaltose, 10 mg), 7,400 times for 67 patients. In total David J Mooney billed 47,095 services in 100 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 7,400 | 67 | $15.93 | $118K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,790 | 20 | $36.88 | $177K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2,540 | 11 | $35.04 | $89K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,175 | 39 | $0.08 | $98.5 |
| 85025 Blood Count | Office | 756 | 263 | $7.54 | $5,700 |
| 36415 Venipuncture Blood Collection | Office | 607 | 243 | $8.59 | $5,211 |
| 99214 Office E&M - Established | Office | 256 | 156 | $87.75 | $22K |
| 96375 Injection Administration | Office | 239 | 45 | $10.68 | $2,552 |
| 96366 Intravenous Infusion, Hydration | Office | 208 | 31 | $14.35 | $2,985 |
| 96372 Injection Administration | Office | 199 | 40 | $9.73 | $1,936 |
| 96365 Intravenous Infusion, Hydration | Office | 193 | 105 | $43.02 | $8,303 |
| 99213 Office E&M - Established | Office | 182 | 138 | $62.43 | $11K |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 97 | 36 | $0.60 | $57.88 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 80 | 19 | $0.86 | $68.51 |
| 96367 Intravenous Infusion, Hydration | Office | 74 | 20 | $19.94 | $1,476 |
By year: 2022 $1.3M for 75,965 services; 2023 $949K for 53,628 services; 2024 $1.1M for 47,095 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 756 | 263 | $7.54 | $5,700 |
| 36415 Venipuncture Blood Collection | 607 | 243 | $8.59 | $5,211 |
Medicare prescription drug claims, 2024
In 2024, the drug David J Mooney prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 190 prescriptions and refills. In total David J Mooney wrote 2,824 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 190 | 190 | 34 | $8,375 |
| Letrozole Generic | 162 | 281 | 32 | $3,021 |
| Eliquis Apixaban | 151 | 184 | 32 | $105K |
| Oxycodone Hcl Generic | 140 | 140 | 18 | $3,506 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 132 | 132 | 27 | $6,177 |
| Ondansetron Hcl Generic | 123 | 133 | 51 | $2,609 |
| Promethazine Hcl Generic | 82 | 84 | 28 | $1,579 |
| Gabapentin Generic | 74 | 99 | 16 | $647 |
| Hydroxyurea Generic | 67 | 108 | 16 | $1,181 |
| Exemestane Generic | 61 | 86 | 13 | $9,758 |
| Levothyroxine Sodium Generic | 61 | 109 | 15 | $386 |
| Pantoprazole Sodium Generic | 57 | 107 | 23 | $774 |
| Xarelto Rivaroxaban | 57 | 67 | Under 11 | $38K |
| Tamoxifen Citrate Generic | 54 | 80 | 13 | $1,382 |
| Xtampza Er Oxycodone Myristate | 53 | 53 | Under 11 | $66K |
Brand drugs: - claims; generic drugs: 2,239 claims; opioid claims: 608.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Mooney $46K ($46K in general payments such as food, travel and fees) from 48 companies. The largest payer was OnMark, Inc. with $41K.
| Company | Payments | Amount |
|---|---|---|
| OnMark, Inc. | 45 | $41K |
| Janssen Biotech, Inc. JNJ | 21 | $466 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $439 |
| Pfizer Inc. PFE | 19 | $388 |
| US Oncology Corporate, Inc. | 4 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $219 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $165 |
| Alexion Pharmaceuticals, Inc. AZN | 8 | $154 |
| Eisai Inc. 4523.T | 9 | $153 |
| Daiichi Sankyo Inc. 4568.T | 7 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.